Craig A. Parish

Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Secondary modification of oxidatively-modified proline N-termini for the construction of complex bioconjugates”.

Secondary modification of oxidatively-modified proline N-termini for the construction of complex bioconjugates

Organic & Biomolecular Chemistry(2020)10.1039/d0ob00211a

N/A

0DataRank · unranked

17 citations

Alexandra V. Ramsey, Meire Mehare, Shane W. Krska, Craig A. Parish, Matthew B. Francis +1 more

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling

Viruses(2024)10.3390/v16071158

N/A

0DataRank · unranked

5 citations

Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological Profiling

Preprints.org(2024)10.20944/preprints202406.1311.v1

N/A

0DataRank · unranked

1 citations

Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more